Pricing Log in Create free account

Autolus Therapeutics PLC Sponsored ADR (AUTL) vs Tectonic Therapeutic, Inc. (TECX)

Autolus Therapeutics PLC Sponsored ADR and Tectonic Therapeutic, Inc. are both Biotechnology companies. Autolus Therapeutics PLC Sponsored ADR and Tectonic Therapeutic, Inc. are of similar size ($376.6M and $371.1M). Tectonic Therapeutic, Inc. has the higher net margin (0.00% vs −238.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Tectonic Therapeutic, Inc. leads on 11 and Autolus Therapeutics PLC Sponsored ADR on 2.

Valuation

Metric AUTL TECX Biotechnology median
P/E n/m n/m 10.64
P/S 3.22 n/m 9.59
P/B 5.05 1.60 2.15
Price to free cash flow n/m n/m 26.07
EV/EBITDA n/m n/m 0.65
EV/Sales 2.15 n/m 9.45
Earnings yield (74.65%) (24.13%) (34.69%)
Free cash flow yield (67.18%) (20.15%) (24.02%)

Profitability

Metric AUTL TECX Biotechnology median
Gross margin 15.66% 0.00% 65.59%
Operating margin (210.78%) 0.00% 0.00%
Net margin (238.66%) 0.00% 0.00%
Free cash flow margin (198.26%) 0.00% 0.00%
Return on equity (133.00%) (33.80%) (51.96%)
Return on assets (46.15%) (32.23%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AUTL TECX Biotechnology median
Revenue growth (TTM) 193.29% — 4.59%
EPS growth (last fiscal year) (25.58%) 40.70% 29.88%
Revenue growth, 5-year CAGR 113.11% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AUTL TECX Biotechnology median
Debt to equity 1.04 0.00 0.00
Current ratio 4.89 22.29 4.86
Net debt to EBITDA 1.16 3.08 1.01

Dividend

Metric AUTL TECX Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric AUTL TECX Biotechnology median
Market cap 376.62m 371.05m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack